← All indications
Vasospasm, Intracranial
Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
Drugs by status
Approved for this indication (1)
Phase 4 trials (5)
Phase 3 trials (3)
Phase 2 trials (12)
Phase 1 trials (1)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (18)
- Harvard University
- Temple University
- Geisinger Clinic
- Iwate Medical University
- Lenox Hill Hospital
- Northwell Health
- Tohoku University
- Thomas Jefferson University
- University of Michigan
- Wake Forest University
- Yale University
- Yamaguchi University
- Mayo Clinic
- University of Texas at Houston
- State University of New York, Buffalo
- University of Illinois at Chicago
- Nakamura Memorial Hospital
- Ootemachi Hospital
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (18)
- Actelion
- Pfizer
- Hope Pharmaceuticals
- American Heart Association
- Case Western Reserve University
- Federal University of Rio Grande do Sul
- University of Washington
- Henry Ford Health System
- Indiana University
- Oregon Health and Science University
- University of Florida
- University of Louisville
- University of Maryland
- University of Nebraska
- University of Virginia
- Icahn School of Medicine at Mount Sinai
- Rush University
- University of Massachusetts
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (3)